Latina, Italy

Antonello Fazio

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonello Fazio: Innovator in Pharmaceutical Chemistry

Introduction

Antonello Fazio is a notable inventor based in Latina, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods of drug preparation. His work is characterized by a focus on improving the efficiency and purity of pharmaceutical compounds.

Latest Patents

Antonello Fazio holds a patent for a method of preparation of metaxalone. This invention involves the reaction of triglycidyl isocyanurate (TGIC) with m-xylenol. The method is distinguished by the use of a solvent mixture that includes an aprotic polar solvent with a dielectric constant greater than or equal to 30, along with other selected solvents. The process is designed to minimize impurities resulting from incomplete reactions and side reactions, thereby enhancing the quality of the final product. He has 1 patent to his name.

Career Highlights

Fazio is associated with Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., a company known for its commitment to pharmaceutical innovation. His work at this organization has allowed him to contribute to advancements in drug formulation and preparation techniques.

Collaborations

Throughout his career, Antonello has collaborated with esteemed colleagues such as Tommaso Iacoangeli and Mario Chiavarini. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Antonello Fazio's contributions to pharmaceutical chemistry through his innovative methods of drug preparation highlight his role as a significant inventor in the industry. His work not only advances the field but also sets a standard for future innovations in drug formulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…